A 40-year-old female patient without any medical history presented to the emergency department with a 3-day history of neck pain and headache. She did not show any other symptoms. Her initial laboratory tests showed slightly increased C-reactive protein (6 mg/L; normal range 0-5 mg/L) and a normal white cell count. There were not observed any other abnormal laboratory finding (leukocyte, 7.4 x 103/uL; hemoglobin, 11.7 gr/dL; platelet, 172 x 103/uL; aspartate aminotransferase, 27 U/L; alanine aminotransferase, 31 U/L). After her neurological examinations, she was hospitalized for further management. She was evaluated with brain and spine MRI to determine neurologic etiologies. The thoracic spine magnetic resonance imaging demonstrated T2 hyperintense right-sided focal lung infiltration (Figure I). The suspicious finding was reported to the referring physician immediately. She was investigated with chest computed tomography for further investigation of this finding. Tomography showed consolidation in the lower lobe of the right lung (Figure II). The differential diagnosis of radiological findings includes viral pneumonia, atypical bacterial pneumonia, pulmonary edema, interstitial lung disease, certain drug-induced, and aspiration pneumonitis. Because of pandemic conditions polymerase chain reaction test was obtained and it confirmed the coronavirus disease 2019 (COVID-19) diagnosis. She received favipiravir treatment for five days. The final diagnosis was COVID-19. The neurologic findings of the patient were disappeared after treatment.
Figure 1.
Figure 2.